87404-0
Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
Active
Term Description
This term was created for, but not limited in use to, the submitter's Theradiag Lisa-Tracker Certolizumab and anti-Certolizumab test kits.
Part Description
LP250847-3 Certolizumab
Certolizumab is a monoclonal antibody conjugated to polyethylene glycol used to treat Crohn's Disease (CD) and rheumatoid arthritis (RA). Certolizumab pegol binds to tumor necrosis factor alpha (TNFα), a pro-inflammatory cytokine that is implicated in the pathogenesis of a number of immunological diseases including CD and RA. TNFα mediates the signature inflammation-induced joint damage in RA. The reduction of TNFα alleviates symptoms of RA, CD and other immunologic diseases. TNFα-inhibitors have been hugely successful in treating immunological diseases. In spite of the positive impact TNFα-inhibitors have had there is still variability in response to their use including loss of response over time and drug tolerance. PMID: 20190560
Source: Regenstrief LOINC
LOINC Names Get Info
- Fully-Specified Name
- Certolizumab:
MCnc: Pt: Ser/Plas: Qn: IA - Long Common Name
- Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
- Short Name
- Certolizumab SerPl IA-mCnc
- Display Name
- Certolizumab IA [Mass/Vol]
- Consumer Name Alpha Get Info
- Certolizumab, Blood
Part Model Get Info
- Component
- Certolizumab
LP250847-3
- Analyte
- Certolizumab
LP250847-3
- Component Numerator
- Certolizumab
LP250847-3
- Component Numerator Core
- Certolizumab
LP250847-3
- Component Numerator Core Suffix
- NULL
- Component Denominator
- NULL
- Component Denominator Core
- NULL
- Component Denominator Core Suffix
- NULL
- Challenge
- NULL
- Adjustment
- NULL
- Count
- NULL
- Property
- MCnc
LP6827-2
- Time
- Pt
LP6960-1
- Time Core
- Pt
LP6960-1
- Time Modifier
- NULL
- System
- Ser/Plas
LP7576-4
- System Core
- Ser/Plas
LP7576-4
- Super System
- NULL
- Scale
- Qn
LP7753-9
- Method
- IA
LP217197-5
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.63
- Last Updated
- Version 2.63 (ADD)
- Order vs. Observation
- Both
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Certolizumab: |
| el-GR | Greek (Greece) | Κερτολιζουμάμπη: Synonyms: DRUG/TOX IA MCnc Pt Qn Κερτολιζουμάμπη Ορός Ορός/Πλάσμα Πλάσμα |
| es-ES | Spanish (Spain) | Certolizumab: Synonyms: Cuantitativo |
| es-MX | Spanish (Mexico) | Certolizumab: |
| fr-FR | French (France) | Certolizumab: |
| it-IT | Italian (Italy) | Certolizumab pegol: Synonyms: Certolizumab pegolo Concentrazione di Massa Immunoassay Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
| nl-NL | Dutch (Netherlands) | certolizumab: Synonyms: IA |
| zh-CN | Chinese (China) | 塞妥珠单抗: Synonyms: 免疫测定; |
Example Units
| Unit | Source |
|---|---|
| ug/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://